Nuciferine

Nuciferine at a Glance

Nuciferine is an aporphine alkaloid concentrated in the leaves of sacred lotus, and present variably in blue lotus.

Preclinical work characterises it as a dopamine D2-family and serotonin 5-HT2 receptor ligand — a receptor profile resembling an atypical antipsychotic more than a typical plant alkaloid, which is what makes it pharmacologically interesting and what underlies the calming effects attributed to lotus preparations.

Two facts undercut the folk reputation. Oral bioavailability in rats is about 2%. And the plant most often sold for the effect — blue lotus — frequently contains almost none of it.

Sacred Lotus vs. Blue Lotus

Two unrelated plants are sold under overlapping names, and nuciferine is only really in one of them.

Sacred lotus (Nelumbo nucifera, Nelumbonaceae) is not a water lily at all — it sits in its own small family, closer to plane trees than to lilies. Its leaf is the drug material, Folium Nelumbinis, used across East and South Asia, and nuciferine is its most abundant alkaloid ^{14Reference 14Nguyen ST et al. · 2025Advancing UPLC-MS/MS for mapping the chemical fingerprint of bioactive compounds in lotus leaves (Folium Nelumbinis)View study →}.

Blue lotus (Nymphaea caerulea, Nymphaeaceae) is a true water lily, the Egyptian one, and the plant sold as a relaxant tea, tincture and vape. Nuciferine is the alkaloid credited with its psychoactivity — and the analytical work does not support the credit. A GC-MS survey of six authentic N. caerulea extracts from trusted sources alongside eleven commercial products found nuciferine and apomorphine virtually absent from the authentic extract ^{13Reference 13Dosoky NS et al. · 2023Chemical composition, market survey and safety assessment of blue lotus (Nymphaea caerulea Savigny) extractsView study →}. Earlier forensic analysis of a confiscated “blue lotus” resin and four commercial products found nuciferine in all five, with 4,300 ng/g in the resin and no apomorphine at all ^{12Reference 12Poklis JL et al. · 2017The blue lotus flower (Nymphaea caerulea) resin used in a new type of electronic cigarette, the re-buildable dripping atomizerView study →}.

So the pattern is the reverse of what a buyer would assume: the authentic flower is nuciferine-poor and the processed commercial “resin” is nuciferine-rich. Something is being added or concentrated somewhere in the supply chain.

In some products it is worse than that. Between 2020 and 2023 a US Army forensic laboratory received 29 seized-drug cases mentioning “blue lotus” or “valerian root”, and 90% of them contained one or more synthetic cannabinoids — most often 5F-MDMB-PICA, ADB-BUTINACA and MDMB-4en-PINACA — alongside 65 toxicology cases with synthetic cannabinoids where the case history mentioned blue lotus. The authors’ conclusion is that innocuous botanical branding conceals the actual psychoactive ingredient, and that sedation, slurred speech and hallucinations attributed to a “botanical extract” should be screened for synthetic cannabinoids ^{16Reference 16Seither JZ et al. · 2024Case reportSynthetic cannabinoid identification in cases associated with blue lotus and valerian root vaping products — case seriesView study →}.

Nuciferine’s real pharmacology, below, is a property of the molecule. It is not an account of what is in a blue-lotus vape.

The Wrong Stereochemistry

Nuciferine’s biosynthesis breaks the rule that governs almost every other benzylisoquinoline plant.

Opium poppy, barberry, goldenseal and the rest build their alkaloids through (S)-configured intermediates, with (S)-reticuline as the branch point from which morphine, berberine and the aporphines all descend. Sacred lotus does neither: its benzylisoquinolines are predominantly (R), and reticuline is absent from the plant entirely ^{15Reference 15Pyne ME et al. · 2023Pathway elucidation and microbial synthesis of proaporphine and bis-benzylisoquinoline alkaloids from sacred lotus (Nelumbo nucifera)View study →}.

The route was worked out in 2023. Lotus CYP80G stereospecifically converts (R)-N-methylcoclaurine to the proaporphine alkaloid glaziovine, which is methylated to pronuciferine, the presumed immediate precursor of nuciferine ^{15Reference 15Pyne ME et al. · 2023Pathway elucidation and microbial synthesis of proaporphine and bis-benzylisoquinoline alkaloids from sacred lotus (Nelumbo nucifera)View study →}. To reproduce the pathway in yeast at all, the authors had to build an artificial stereochemical inversion — borrowing dehydroreticuline synthase from common poppy and pairing it with dehydroreticuline reductase — to turn (S)-norcoclaurine into the (R) intermediate the lotus enzymes require.

The practical consequence is that lotus alkaloids cannot be made by extending an opium-poppy biosynthetic platform, and that nuciferine’s stereochemistry — it is (R)-1,2-dimethoxyaporphine — is not an incidental detail but the signature of a separate evolutionary route to the same ring system.

What It's Used For

Nuciferine’s most rigorous characterisation is receptor pharmacology. A full NIMH-PDSP screen defined an “aripiprazole-like” polypharmacology — dopamine D2-family partial agonism, 5-HT2A/2C antagonism, 5-HT1A agonism and dopamine-transporter inhibition — with matching in-vivo signatures: it blocked the DOI head-twitch response and substituted for the clozapine discriminative cue in mice ^{1Reference 1Farrell MS et al. · 2016AnimalIn-vitro and in-vivo characterisation of the alkaloid nuciferine — animal in vivoView study →}.

Everything else is rodent efficacy work, most of it metabolic, and all of it dosed orally against an absolute bioavailability of about 2% ^{10Reference 10Wang F et al. · 2018AnimalPharmacokinetics, tissue distribution, bioavailability and excretion of nuciferine, an alkaloid from lotus, in rats by LC/MS/MS — animalView study →}.

Evidence by IndicationStrength of support · Beta

01CNS / receptor pharmacologyShaky40%One rigorous in-vitro + in-vivo characterization ^{1,2Reference 1Farrell MS et al. · 2016AnimalIn-vitro and in-vivo characterisation of the alkaloid nuciferine — animal in vivoView study →Reference 2Liu Y et al. · 2026ReviewInsights into nuciferine: a natural multifunctional bioactive alkaloid — reviewView study →}

02Metabolic / anti-obesityShaky40%Multiple independent rodent HFD models ^{3,4,5Reference 3Wang Y et al. · 2020AnimalNuciferine modulates the gut microbiota and prevents obesity in high-fat-diet-fed rats — animal in vivoView study →Reference 4Shi Z et al. · 2021AnimalNuciferine improves high-fat-diet-induced obesity via reducing intestinal permeability by increasing autophagy and remodeling the gut microbiota — animal in vivoView study →Reference 5Xu H et al. · 2022AnimalDistinct AMPK-mediated FAS/HSL pathway is implicated in the alleviating effect of nuciferine on obesity and hepatic steatosis in HFD-fed mice — animal in vivoView study →}

03Anti-inflammatory / renalShaky28%Two rodent inflammation/renal models ^{8,9Reference 8Wang MX et al. · 2015AnimalNuciferine restores potassium-oxonate-induced hyperuricemia and kidney inflammation in mice — animal in vivoView study →Reference 9Wang MX et al. · 2016AnimalNuciferine alleviates renal injury by inhibiting inflammatory responses in fructose-fed rats — animal in vivoView study →}

04HepatoprotectiveShaky28%Diabetic/HFD steatosis models ^{6,7Reference 6Zhang C et al. · 2018AnimalNuciferine ameliorates hepatic steatosis in high-fat-diet/streptozocin-induced diabetic mice through a PPARα/PPARγ coactivator-1α pathway — animal in vivoView study →Reference 7Ning Q et al. · 2019AnimalNuciferine prevents hepatic steatosis by regulating lipid metabolism in a diabetic rat model — animal in vivoView study →}

05AntidiabeticShaky20%Single T2DM rodent study ^{11Reference 11Zheng M et al. · 2026AnimalNuciferine ameliorates cognitive impairment and insulin resistance in T2DM by targeting the insulin receptor and activating PI3K/AKT signalling — animal in vivoView study →}

Mechanisms

Clinical trials

There are no controlled human trials of isolated nuciferine for any indication. The only human-relevant data are analytical surveys of blue-lotus consumer products ^{12,13Reference 12Poklis JL et al. · 2017The blue lotus flower (Nymphaea caerulea) resin used in a new type of electronic cigarette, the re-buildable dripping atomizerView study →Reference 13Dosoky NS et al. · 2023Chemical composition, market survey and safety assessment of blue lotus (Nymphaea caerulea Savigny) extractsView study →}, not dosing studies; all efficacy evidence is preclinical.

Last checked: July 2026.

Pharmacokinetics

The single most important translational fact about nuciferine is that almost none of an oral dose gets in. Measured against an intravenous reference at 10 mg/kg in rats, absolute oral bioavailability is 1.9% ^{10Reference 10Wang F et al. · 2018AnimalPharmacokinetics, tissue distribution, bioavailability and excretion of nuciferine, an alkaloid from lotus, in rats by LC/MS/MS — animalView study →}. What does get in distributes fast and widely, with tissue exposure ranking kidney > lung > spleen > liver > brain > heart — so it does reach the brain, consistent with the CNS pharmacology — and roughly half of an oral dose is excreted renally as unchanged parent drug ^{10Reference 10Wang F et al. · 2018AnimalPharmacokinetics, tissue distribution, bioavailability and excretion of nuciferine, an alkaloid from lotus, in rats by LC/MS/MS — animalView study →}.

Two consequences follow. Rodent efficacy doses of 10–50 mg/kg are delivering systemic exposure of a few per cent of that, so the concentrations at which the receptor pharmacology was characterised are not obviously reached by eating the plant. And a human dose cannot be inferred by body-surface conversion from a rodent dose when the absorbed fraction is this small and this variable.

All pharmacokinetics are rodent. There is no human data of any kind.

Isolate vs. Plant Studies

Every efficacy result for nuciferine is an isolate result. The receptor screen used purified compound ^{1Reference 1Farrell MS et al. · 2016AnimalIn-vitro and in-vivo characterisation of the alkaloid nuciferine — animal in vivoView study →}; the obesity, steatosis, hyperuricaemia and renal studies all dosed purified compound to rodents ^{3,4,5,6,7,8,9Reference 3Wang Y et al. · 2020AnimalNuciferine modulates the gut microbiota and prevents obesity in high-fat-diet-fed rats — animal in vivoView study →Reference 4Shi Z et al. · 2021AnimalNuciferine improves high-fat-diet-induced obesity via reducing intestinal permeability by increasing autophagy and remodeling the gut microbiota — animal in vivoView study →Reference 5Xu H et al. · 2022AnimalDistinct AMPK-mediated FAS/HSL pathway is implicated in the alleviating effect of nuciferine on obesity and hepatic steatosis in HFD-fed mice — animal in vivoView study →Reference 6Zhang C et al. · 2018AnimalNuciferine ameliorates hepatic steatosis in high-fat-diet/streptozocin-induced diabetic mice through a PPARα/PPARγ coactivator-1α pathway — animal in vivoView study →Reference 7Ning Q et al. · 2019AnimalNuciferine prevents hepatic steatosis by regulating lipid metabolism in a diabetic rat model — animal in vivoView study →Reference 8Wang MX et al. · 2015AnimalNuciferine restores potassium-oxonate-induced hyperuricemia and kidney inflammation in mice — animal in vivoView study →Reference 9Wang MX et al. · 2016AnimalNuciferine alleviates renal injury by inhibiting inflammatory responses in fructose-fed rats — animal in vivoView study →}. No study has given lotus leaf, or a lotus-leaf extract, and attributed the outcome to nuciferine ^{17Reference 17Ren X et al. · 2024ReviewAdvances in the pharmacological effects and mechanisms of Nelumbo nucifera Gaertn. extract nuciferine — reviewView study →}.

That is not because plant preparations are unstudied — Folium Nelumbinis has a large traditional and modern literature — but because nobody has bridged the two. The bridge would be hard to build: at 1.9% oral bioavailability ^{10Reference 10Wang F et al. · 2018AnimalPharmacokinetics, tissue distribution, bioavailability and excretion of nuciferine, an alkaloid from lotus, in rats by LC/MS/MS — animalView study →}, the leaf would have to deliver a great deal of nuciferine to reach the concentrations the isolate work uses.

The blue-lotus side is worse than unbridged. It is actively misleading. Authentic Nymphaea caerulea extract is virtually free of nuciferine ^{13Reference 13Dosoky NS et al. · 2023Chemical composition, market survey and safety assessment of blue lotus (Nymphaea caerulea Savigny) extractsView study →}, while the commercial products that carry the reputation contain variable amounts of it ^{12Reference 12Poklis JL et al. · 2017The blue lotus flower (Nymphaea caerulea) resin used in a new type of electronic cigarette, the re-buildable dripping atomizerView study →} and, in a large forensic series, mostly contained synthetic cannabinoids instead ^{16Reference 16Seither JZ et al. · 2024Case reportSynthetic cannabinoid identification in cases associated with blue lotus and valerian root vaping products — case seriesView study →}. A consumer effect attributed to blue lotus cannot be assumed to be a nuciferine effect at all.

Prevalence in Nature

Nuciferine is essentially a sacred-lotus alkaloid. Nelumbo nucifera (Nelumbonaceae) accumulates it principally in the leaf — the drug material Folium Nelumbinis — with smaller amounts in the plumule (the green embryo of the seed) and rhizome. A UPLC-MS/MS survey of 49 lotus-leaf samples from across Vietnam, spanning regions and growth stages, found nuciferine the most abundant alkaloid measured, with significant regional and developmental variation and the highest alkaloid concentrations in the Hanoi samples ^{14Reference 14Nguyen ST et al. · 2025Advancing UPLC-MS/MS for mapping the chemical fingerprint of bioactive compounds in lotus leaves (Folium Nelumbinis)View study →}. It travels with its demethylated relatives O-nornuciferine and N-nornuciferine, which the same method quantifies alongside it.

In blue lotus (Nymphaea caerulea, Nymphaeaceae — an unrelated family) nuciferine is reported but scarce: authenticated extracts from trusted sources were found to contain it only in trace amounts, while processed commercial “resins” reached ~4,300 ng/g ^{12,13Reference 12Poklis JL et al. · 2017The blue lotus flower (Nymphaea caerulea) resin used in a new type of electronic cigarette, the re-buildable dripping atomizerView study →Reference 13Dosoky NS et al. · 2023Chemical composition, market survey and safety assessment of blue lotus (Nymphaea caerulea Savigny) extractsView study →}.

No percentage-of-dry-weight figure has been published for nuciferine in lotus leaf that could be compared across sources, which is why no Content by Source chart appears here — the analytical work reports relative abundance and regional variation rather than absolute content.

Major Natural Sources

Source	Part	Level	Note
Sacred lotus (Nelumbo nucifera)	leaf	most abundant alkaloid present	strong regional and growth-stage variation across 49 samples 14Reference 14Nguyen ST et al. · 2025Advancing UPLC-MS/MS for mapping the chemical fingerprint of bioactive compounds in lotus leaves (Folium Nelumbinis)View study →
Sacred lotus (Nelumbo nucifera)	plumule, rhizome	minor	the plumule is the traditional sedative part
Blue lotus (Nymphaea caerulea)	authentic flower extract	virtually absent	six authenticated extracts, GC-MS 13Reference 13Dosoky NS et al. · 2023Chemical composition, market survey and safety assessment of blue lotus (Nymphaea caerulea Savigny) extractsView study →
Blue lotus commercial “resin”	processed product	~4,300 ng/g in one confiscated sample	not a plant figure — a manufactured one 12Reference 12Poklis JL et al. · 2017The blue lotus flower (Nymphaea caerulea) resin used in a new type of electronic cigarette, the re-buildable dripping atomizerView study →

Discovery & Synthesis

Nuciferine is named for Nelumbo nucifera and was characterised as part of the long twentieth-century working-out of lotus alkaloid chemistry, much of it Japanese; a single first-isolation date and discoverer are not reliably fixed in the accessible record. Its systematic identity is (R)-1,2-dimethoxyaporphine.

Racemic nuciferine has been synthesised: a 2003 route reached both (±)-nuciferine and (±)-lirinidine by an intramolecular ortho-arylation of a phenol, closing the aporphine biaryl bond directly ^{18Reference 18Cuny GD · 2003Intramolecular ortho-arylation of phenols utilised in the synthesis of the aporphine alkaloids (±)-lirinidine and (±)-nuciferineView study →}. More recently the biosynthetic route has been reconstructed in microbes — lotus CYP80G plus a methyltransferase delivering pronuciferine, nuciferine’s presumed precursor, in an engineered host ^{15Reference 15Pyne ME et al. · 2023Pathway elucidation and microbial synthesis of proaporphine and bis-benzylisoquinoline alkaloids from sacred lotus (Nelumbo nucifera)View study →}, which is the plausible future supply route for lotus alkaloids generally.

Today it is extracted, from lotus leaf, and sold as a research chemical and as a marker compound for Folium Nelumbinis quality control ^{14Reference 14Nguyen ST et al. · 2025Advancing UPLC-MS/MS for mapping the chemical fingerprint of bioactive compounds in lotus leaves (Folium Nelumbinis)View study →}. There is no pharmaceutical product containing it.

Patents: not yet researched (future patent-loop pass).

Toxicity & Safety

The moderate flag is not about organ toxicity — it rests on brain-penetrant receptor activity meeting an unregulated recreational market, where blue-lotus product content is so variable that no one can dose reliably.

Safety at a Glance

⚠️ Moderate toxicityDrug interactionsSedative interactions

• Blue-lotus vape products are frequently adulterated. In a US Army forensic series, 90% of seized cases mentioning “blue lotus” or “valerian root” contained synthetic cannabinoids.
• Unreliable real-world exposure. Blue-lotus vape and tea content is wildly variable — virtually absent from authentic extracts, elevated in processed “resins” — so effects may come from other constituents or adulterants.
• Avoid in pregnancy and lactation. No reproductive or developmental toxicology.
• Theoretical dopaminergic interactions. D2 partial agonism could interact with antipsychotics, dopamine agonists and antiemetics.
• Theoretical serotonergic interactions. 5-HT1A and 5-HT2 activity alongside SSRIs, SNRIs, triptans and other serotonergic agents.
• Additive sedation with CNS depressants. Inferred from its receptor pharmacology, not observed clinically.
• Direct toxicity signals are mild. Preclinical work has not shown documented organ toxicity.

Full Safety & Interactions Detail

The isolated compound’s human safety is uncharacterized, and preclinical direct-toxicity signals are mild — so the moderate flag rests mainly on its CNS receptor activity, brain penetration and real-world unregulated recreational exposure, not on documented organ toxicity. The recreational context is itself the larger hazard, and it is documented rather than theoretical. Nuciferine is the cited psychoactive marker of blue-lotus vapes and teas, but authentic Nymphaea caerulea extract is virtually free of it ^{13Reference 13Dosoky NS et al. · 2023Chemical composition, market survey and safety assessment of blue lotus (Nymphaea caerulea Savigny) extractsView study →} while processed “resins” carry variable amounts ^{12Reference 12Poklis JL et al. · 2017The blue lotus flower (Nymphaea caerulea) resin used in a new type of electronic cigarette, the re-buildable dripping atomizerView study →} — so consumers cannot dose reliably. Worse, between 2020 and 2023 a US Army forensic laboratory found synthetic cannabinoids in 90% of 29 seized cases mentioning “blue lotus” or “valerian root”, with 65 matching toxicology cases; 5F-MDMB-PICA, ADB-BUTINACA and MDMB-4en-PINACA were the most frequent. The paper’s recommendation is that any adverse effect attributed to these botanicals — erratic behaviour, sedation, slurred speech, hallucinations — be screened for synthetic cannabinoids rather than assumed botanical ^{16Reference 16Seither JZ et al. · 2024Case reportSynthetic cannabinoid identification in cases associated with blue lotus and valerian root vaping products — case seriesView study →}.

The interaction profile is theoretical, from its receptor pharmacology: dopaminergic (D2 partial agonism could interact with antipsychotics, dopamine agonists and antiemetics), serotonergic (5-HT1A/5-HT2 activity with SSRIs/SNRIs, triptans and other serotonergic agents), and additive sedation with CNS depressants — none observed clinically.

Dosage

There is no established human dose, and none should be stated.

Body-surface conversion from the rodent figures is not meaningful when the absorbed fraction is under 2% and variable ^{10Reference 10Wang F et al. · 2018AnimalPharmacokinetics, tissue distribution, bioavailability and excretion of nuciferine, an alkaloid from lotus, in rats by LC/MS/MS — animalView study →}. Real-world blue-lotus exposure cannot be framed as a dose at all: product content is unreliable ^{13Reference 13Dosoky NS et al. · 2023Chemical composition, market survey and safety assessment of blue lotus (Nymphaea caerulea Savigny) extractsView study →} and frequently is not nuciferine ^{16Reference 16Seither JZ et al. · 2024Case reportSynthetic cannabinoid identification in cases associated with blue lotus and valerian root vaping products — case seriesView study →}. These are doses studied in research and are not a personal recommendation.

References

1. Farrell MS, McCorvy JD, Huang XP, et al. (2016). In-vitro and in-vivo characterisation of the alkaloid nuciferine — animal in vivo. PLoS One. https://pubmed.ncbi.nlm.nih.gov/26963248/
2. Liu Y, Li X, Huang B, et al. (2026). Insights into nuciferine: a natural multifunctional bioactive alkaloid — review. Molecular Medicine Reports. https://pubmed.ncbi.nlm.nih.gov/42028734/
3. Wang Y, Yao W, Li B, et al. (2020). Nuciferine modulates the gut microbiota and prevents obesity in high-fat-diet-fed rats — animal in vivo. Experimental & Molecular Medicine. https://pubmed.ncbi.nlm.nih.gov/33262480/
4. Shi Z, Fang ZY, Gao XX, et al. (2021). Nuciferine improves high-fat-diet-induced obesity via reducing intestinal permeability by increasing autophagy and remodeling the gut microbiota — animal in vivo. Food & Function. https://pubmed.ncbi.nlm.nih.gov/34018523/
5. Xu H, Lyu X, Guo X, et al. (2022). Distinct AMPK-mediated FAS/HSL pathway is implicated in the alleviating effect of nuciferine on obesity and hepatic steatosis in HFD-fed mice — animal in vivo. Nutrients. https://pubmed.ncbi.nlm.nih.gov/35565866/
6. Zhang C, Deng J, Liu D, et al. (2018). Nuciferine ameliorates hepatic steatosis in high-fat-diet/streptozocin-induced diabetic mice through a PPARα/PPARγ coactivator-1α pathway — animal in vivo. British Journal of Pharmacology. https://pubmed.ncbi.nlm.nih.gov/30129056/
7. Ning Q, Wang Y, Zhang Y, et al. (2019). Nuciferine prevents hepatic steatosis by regulating lipid metabolism in a diabetic rat model — animal in vivo. Open Life Sciences. https://pubmed.ncbi.nlm.nih.gov/33817209/
8. Wang MX, Liu YL, Yang Y, et al. (2015). Nuciferine restores potassium-oxonate-induced hyperuricemia and kidney inflammation in mice — animal in vivo. European Journal of Pharmacology. https://pubmed.ncbi.nlm.nih.gov/25499818/
9. Wang MX, Zhao XJ, Chen TY, et al. (2016). Nuciferine alleviates renal injury by inhibiting inflammatory responses in fructose-fed rats — animal in vivo. Journal of Agricultural and Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/27718563/
10. Wang F, Cao J, Hou X, et al. (2018). Pharmacokinetics, tissue distribution, bioavailability and excretion of nuciferine, an alkaloid from lotus, in rats by LC/MS/MS — animal. Drug Development and Industrial Pharmacy. https://pubmed.ncbi.nlm.nih.gov/29909691/
11. Zheng M, Wang C, Liu J, et al. (2026). Nuciferine ameliorates cognitive impairment and insulin resistance in T2DM by targeting the insulin receptor and activating PI3K/AKT signalling — animal in vivo. Chinese Journal of Natural Medicines. https://pubmed.ncbi.nlm.nih.gov/42285687/
12. Poklis JL, Mulder HA, Halquist MS, et al. (2017). The blue lotus flower (Nymphaea caerulea) resin used in a new type of electronic cigarette, the re-buildable dripping atomizer. Journal of Psychoactive Drugs. https://pubmed.ncbi.nlm.nih.gov/28266899/
13. Dosoky NS, Shah SA, Dawson JT, et al. (2023). Chemical composition, market survey and safety assessment of blue lotus (Nymphaea caerulea Savigny) extracts. Molecules. https://pubmed.ncbi.nlm.nih.gov/37894493/
14. Nguyen ST, Nguyen HTT, Nguyen DCT, et al. (2025). Advancing UPLC-MS/MS for mapping the chemical fingerprint of bioactive compounds in lotus leaves (Folium Nelumbinis). Journal of Pharmaceutical and Biomedical Analysis. https://pubmed.ncbi.nlm.nih.gov/40174513/
15. Pyne ME, Gold ND, Martin VJJ (2023). Pathway elucidation and microbial synthesis of proaporphine and bis-benzylisoquinoline alkaloids from sacred lotus (Nelumbo nucifera). Metabolic Engineering. https://pubmed.ncbi.nlm.nih.gov/37004909/
16. Seither JZ, Karschner EL, Jackson KR, et al. (2024). Synthetic cannabinoid identification in cases associated with blue lotus and valerian root vaping products — case series. Journal of Analytical Toxicology. https://pubmed.ncbi.nlm.nih.gov/39082147/
17. Ren X, Chen H, Wang H, et al. (2024). Advances in the pharmacological effects and mechanisms of Nelumbo nucifera Gaertn. extract nuciferine — review. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/38670406/
18. Cuny GD (2003). Intramolecular ortho-arylation of phenols utilised in the synthesis of the aporphine alkaloids (±)-lirinidine and (±)-nuciferine. Tetrahedron Letters. https://doi.org/10.1016/j.tetlet.2003.09.026

View all 18 references▾